(19)
(11) EP 1 292 279 A1

(12)

(43) Date of publication:
19.03.2003 Bulletin 2003/12

(21) Application number: 01941973.8

(22) Date of filing: 05.06.2001
(51) International Patent Classification (IPC)7A61K 9/00, A61K 38/00, A61F 13/00, A61F 9/02
(86) International application number:
PCT/US0118/248
(87) International publication number:
WO 0109/3828 (13.12.2001 Gazette 2001/50)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 05.06.2000 US 587523

(71) Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
49131 Petah Tiqva (IL)

(72) Inventors:
  • YONG, V., Wee
    Calgary, Alberta T3A 2Z1 (CA)
  • CHABOT, Sophie
    Bell, Quebec G0R 2Y0 (CA)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) THE USE OF GLATIRAMER ACETATE (COPOLYMER 1) IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS